Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
Researchers at Penn Medicine have uncovered how common diabetes medications could swiftly improve heart function by activating an enzyme essential for energy production, offering new avenues for heart failure therapy. A common class of diabetes medicines may protect failing hearts…
As the use of semaglutide and tirzepatide for weight management gains global attention, Brazilian authorities stress that these drugs are not interchangeable, urging careful medical assessment amid rising demand and concerns over safety and misuse. Semaglutide and tirzepatide have turned…
Keith Runyan, a physician with type 1 diabetes, reports that a low-carbohydrate ketogenic approach combined with regular exercise and structured meals has significantly improved his blood glucose stability, challenging conventional management protocols. Keith Runyan, a physician who writes regularly about…
MiniMed submits its first patch pump for US regulatory approval, alongside advancements in automated insulin delivery and longer-lasting glucose sensors, signalling a potential shift in diabetes care innovation. MiniMed has filed for US regulatory clearance for its first patch pump,…
Eli Lilly’s Mounjaro (tirzepatide) secures expanded US approval to lower major cardiovascular events in adults with type 2 diabetes at high risk of heart disease, marking a significant shift in diabetes management practices. Eli Lilly’s Mounjaro has won expanded US…
A new report highlights the link between excessive sugar intake, lifestyle factors, and the increasing prevalence of kidney disease among young adults in Indonesia, prompting calls for early detection and comprehensive care. Excess sugar does not directly trigger kidney failure,…
Research suggests sesamin, a compound in sesame seeds, enhances endothelial cell resilience to high glucose and speeds healing in diabetic wounds by activating Nrf2, a key cellular defence regulator. Sesamin, a compound found in sesame seeds, may help protect blood…
A UK-based study highlights how men and women with type 2 diabetes experience different complication patterns, prompting calls for personalised monitoring and treatment approaches to improve outcomes. A new PLOS Medicine study suggests that type 2 diabetes does not affect…
A new review suggests continuous glucose monitors could play a pivotal role in preventing heart disease even in people without diabetes, by revealing blood sugar fluctuations that traditional tests might miss. A review posted on Rapamycin News argues that continuous…
Verily has developed the first multimodal foundation model combining electronic health records with genomic data, enhancing disease risk prediction, with support from NVIDIA and the US NIH’s All of Us Research Program, signalling a potential leap forward in personalised healthcare.…
New research from the ESC Congress 2026 reveals that metformin does not reduce major cardiovascular events in patients with heart failure with reduced ejection fraction, challenging previous observational hints of cardioprotective effects. At the ESC Congress 2026 in Madrid, researchers…
Researchers at the University of Maryland have developed a diabetes risk tool that predicts the likelihood of complications in the near term, enabling doctors to target prevention more effectively and adapt care plans based on routine clinical data. Researchers at…
